Concentric Capital Strategies’s Evolent Health EVH Stock Holding History

Concentric Capital Strategies’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-44,475	Closed	-$376K	–	300
2025 Q3	$376K	Buy	+44,475	New	+$432K	0.02%	280

Other funds holding EVH

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Concentric Capital Strategies's EVH Position: Q4 2025 in Review

Concentric Capital Strategies sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 44,475 shares — an estimated $376K sold.

Concentric Capital Strategies first reported a position in EVH in Q3 2025 and held it in 1 quarter. The position peaked at $376K in Q3 2025. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

Concentric Capital Strategies reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
Concentric Capital Strategies sold 44,475 Evolent Health shares in Q4 2025, an estimated $376K.
Concentric Capital Strategies first reported a position in Evolent Health in Q3 2025 and held it in 1 quarter.
Concentric Capital Strategies's Evolent Health position peaked at $376K in Q3 2025.
215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Concentric Capital Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.